Practice Points Developed for Treatment of Outpatient COVID-19
Medically reviewed by Drugs.com.
By Elana Gotkine HealthDay Reporter
WEDNESDAY, Sept. 20, 2023 -- In an updated clinical guideline issued by the American College of Physicians and published online Sept. 19 in the Annals of Internal Medicine, living, rapid practice points are presented for the outpatient treatment of confirmed COVID-19.
Amir Qaseem, M.D., Ph.D., from the American College of Physicians in Philadelphia, and colleagues developed living, rapid practice points focusing on 22 outpatient treatments for COVID-19, specifically relating to the omicron variant.
The authors note that molnupiravir should be considered for treating symptomatic patients with confirmed mild-to-moderate COVID-19 in the outpatient setting who are within five days of symptom onset and who have a high risk for progression to severe disease. For symptomatic patients with mild-to-moderate COVID-19 in the outpatient setting who are within five days of symptom onset and have a high risk for progression to severe disease, nirmatrelvir-ritonavir combination therapy should also be considered. Ivermectin should not be used for patients with confirmed mild-to-moderate COVID-19 in the outpatient setting. Sotrovimab should also not be used for patients with confirmed mild-to-moderate COVID-19 in the outpatient setting.
"More research evaluating the efficacy, effectiveness, and comparative effectiveness, as well as harms, of pharmacologic and biologic treatments of COVID-19 in the outpatient setting is needed, particularly in the context of changing dominant severe acute respiratory syndrome coronavirus 2 variants and subvariants," the authors write.
One author disclosed financial ties to Eli Lilly.
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2024 HealthDay. All rights reserved.
Posted September 2023
Further Support and Information on COVID-19
Read this next
Mortality in Rheumatic Heart Disease Is High
FRIDAY, June 7, 2024 -- Mortality related to rheumatic heart disease (RHD) is high and is correlated with the severity of valve disease, according to a study published online June...
Higher County-Level Prostate Cancer Screening Tied to Better Outcomes
FRIDAY, June 7, 2024 -- Higher county-level prevalence of prostate-specific antigen (PSA) screening is associated with lower odds of advanced disease, all-cause mortality, and...
Metabolic Impact on Offspring Similar for Frozen, Fresh Embryo Transfer
FRIDAY, June 7, 2024 -- For glucose and lipid profiles during early childhood, the impact of frozen embryo transfer (FET) is comparable to that of fresh embryo transfer, according...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.